A series of factors such as oncogenic receptor tyrosine kinases, RAS/MAP kinase, PI3K/AKT/S6K, DYRK1A, PKC, TGF-β, and histone deacetylases could enhance the transcriptional activity of GLIs in human cancer cells34,35. This evidence concerns the gene DYRK1A and cancer.